Paladin Labs Inc.(PLB.TO) announced that it has acquired all the outstanding shares ViRexx Medical Corp.(VIR.TO, REX).
Paladin paid $1.25 million payable to existing ViRexx creditors. In addition, former ViRexx shareholders could receive a payment of up to $2.50 million, if certain conditions are met before December 31, 2009.
As a result of this transaction, Paladin will be spending approximately $2 million - $2.5 million in R&D in 2009 on the Chimigen platform and partnering activities. In addition, Paladin's non-capital losses and investment tax credits available to offset future taxable income has increased by a minimum of $28 million.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.